Literature DB >> 11967289

Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera.

Craig Meyers1, Jennifer L Bromberg-White, Jiaping Zhang, Michelle E Kaupas, Janine T Bryan, Robert S Lowe, Kathrin U Jansen.   

Abstract

The organotypic raft culture system has allowed the study of the differentiation-dependent aspects of the human papillomavirus (HPV) life cycle. However, genetic strategies to more completely understand the HPV life cycle are limited. The generation of chimeric viruses has been a useful tool in other virus systems to analyze infection and replication. To investigate the specificity of the interaction of nonstructural genes of one HPV type with the structural genes of another HPV type, we have replaced the L2 and L1 open reading frames (ORFs) of HPV type 18 (HPV18) with the L2 and L1 ORFs of HPV type 16 (HPV16). The resulting HPV18/16 chimeric construct was introduced into primary keratinocytes, where it was stably maintained episomally at a range of 50 to 100 copies of HPV genomic DNA, similar to that typically found in HPV-infected cells in vivo. The integrity of the HPV18/16 genomic DNA chimera was demonstrated. Upon differentiation in raft cultures, late viral functions, including viral DNA amplification, capsid gene expression, and virion morphogenesis, occurred. Chimeric HPV18/16 virions were purified from the raft cultures and were capable of infecting keratinocytes in vitro. Additionally, infection was specifically neutralized with human HPV16 virus-like particle (VLP)-specific antiserum and not with human HPV18 VLP-specific antiserum. Our data demonstrate that the nonstructural genes of HPV18 functionally interact with the structural genes of HPV16, allowing the complete HPV life cycle to occur. We believe that this is the first report of the propagation of chimeric HPV by normal life cycle pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967289      PMCID: PMC136126          DOI: 10.1128/jvi.76.10.4723-4733.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  DNA replication of chimeric JC virus-simian virus 40 genomes.

Authors:  K J Lynch; S Haggerty; R J Frisque
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

2.  In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Authors:  R B Roden; H L Greenstone; R Kirnbauer; F P Booy; J Jessie; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

3.  Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA.

Authors:  K Grassmann; B Rapp; H Maschek; K U Petry; T Iftner
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.

Authors:  J Gall; A Kass-Eisler; L Leinwand; E Falck-Pedersen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition.

Authors:  R B Roden; N L Hubbert; R Kirnbauer; N D Christensen; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability.

Authors:  J E Tavis; P W Trowbridge; R J Frisque
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

7.  Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12.

Authors:  G C Telling; J Williams
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

8.  Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro.

Authors:  L H Smith; C Foster; M E Hitchcock; G S Leiserowitz; K Hall; R Isseroff; N D Christensen; J W Kreider
Journal:  J Invest Dermatol       Date:  1995-09       Impact factor: 8.551

9.  Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity.

Authors:  A M Daniel; J J Swenson; R P Mayreddy; K Khalili; R J Frisque
Journal:  Virology       Date:  1996-02-01       Impact factor: 3.616

10.  In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression.

Authors:  M G Frattini; H B Lim; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  19 in total

1.  Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1.

Authors:  Kong-Nan Zhao; Ian H Frazer
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Study of infectious virus production from HPV18/16 capsid chimeras.

Authors:  Horng-Shen Chen; Jennifer Bromberg-White; Michael J Conway; Samina Alam; Craig Meyers
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

3.  Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

4.  Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.

Authors:  Brian S Bowser; Horng-Shen Chen; Michael J Conway; Neil D Christensen; Craig Meyers
Journal:  Virus Res       Date:  2011-07-06       Impact factor: 3.303

5.  Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription.

Authors:  Michelle A Ozbun
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene.

Authors:  Samina Alam; Brian S Bowser; Michael J Conway; Mohd Israr; Eric J Ryndock; Long Fu Xi; Craig Meyers
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

7.  Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter.

Authors:  Jason M Bodily; Craig Meyers
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis.

Authors:  Samina Alam; Michael J Conway; Horng-Shen Chen; Craig Meyers
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine.

Authors:  Subhashini Jagu; Kihyuck Kwak; John T Schiller; Douglas R Lowy; Harold Kleanthous; Kirill Kalnin; Chenguang Wang; Hsu-Kun Wang; Louise T Chow; Warner K Huh; Kilvani S Jaganathan; Sudha V Chivukula; Richard B S Roden
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

10.  Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism.

Authors:  John H Lee; Su Min P Yi; Mary E Anderson; Kristi L Berger; Michael J Welsh; Aloysius J Klingelhutz; Michelle A Ozbun
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.